Slow Day to Start Busy Week | Wall Street Today
Sector Update: Health Care Stocks Edge Up Monday Afternoon
Sector Update: Health Care
Market Climbs as Investors Prepare for Biggest Earnings Week of the Year | Live Stock
Top Midday Stories: Boeing Launches Public Offerings; McDonald's Quarter Pounder to Return to Menus This Week
AbbVie Is Buying an Alzheimer's Drug for More Than $1 Billion
AbbVie (ABBV.US) invests $1.4 billion to acquire the neuroscience technology company Aliada Therapeutics.
AbbVie has agreed to acquire all outstanding shares of Aliada Therapeutics, a biotechnology company focused on neuroscience, for 1.4 billion US dollars in cash.
Sweetgreen, Tesla, Digital Realty Trust And A Health Care Stock On CNBC's 'Final Trades'
AbbVie to Acquire Aliada Therapeutics for $1.4B in Cash
Express News | Abbvie to Acquire Aliada Therapeutics, Strengthening Focus in Alzheimer's Disease and Neuroscience Pipeline
Press Release: AbbVie to Acquire Aliada Therapeutics, Strengthening Focus in Alzheimer's Disease and Neuroscience Pipeline
Apple, Microsoft, Exxon, and More Stocks to Watch
About 75% of Companies That Reported Earnings This Week Delivered EPS Wins-Earnings Scorecard
Preview -- Barron's
Forecasting The Future: 11 Analyst Projections For AbbVie
Weekly Buzz: Is Tesla a sign of earnings to come?
Friday Market Falls With Busy Business Ahead | Wall Street Today
AbbVie Is Maintained at Buy by Citigroup
AbbVie Analyst Ratings
Express News | CNBC Halftime Report Final Trades: Tesla, Sweetgreen, AbbVie, Digital Realty Trust